Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Transforming function of the LSM1 oncogene in human breast cancers with the 8p11–12 amplicon

Abstract

Amplification of the 8p11–12 region occurs in 15–20% of breast cancers, but the driving oncogene at this locus has yet to be definitively identified. We mapped the 8p11–12 amplicon in breast cancer cell lines and primary human breast cancers and identified the candidate oncogene human Sm-like protein (hLsm1, LSM1) based on increases in copy number and expression level relative to human mammary epithelial cells. To examine the oncogenic role of LSM1, we overexpressed this gene in MCF10A mammary epithelial cells and inhibited its production in the SUM44 breast cancer cell line, which has a natural amplification and overexpression of LSM1. Our data confirmed that LSM1 is an oncogene from the 8p11–12 amplicon by showing that hLsm1 overexpression induced growth factor-independent proliferation and soft agar colony formation in MCF10A cells, and hLsm1 inhibition in SUM44 cells dramatically reduced soft agar growth. Little is known about hLsm1 function other than its involvement in mRNA degradation; therefore, we used expression microarray analysis to investigate how hLsm1 affects cell transformation in MCF10A and SUM44 cells. We identified numerous genes altered following hLsm1 overexpression common to SUM44 breast cancer cells that play important roles in cell cycle regulation, cell proliferation and other cancer-promoting processes. Future work will continue to characterize these important changes to achieve a more complete understanding of the mechanism of hLsm1's effect on cancer progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Bouveret E, Rigaut G, Shevchenko A, Wilm M, Seraphin B . (2000). A Sm-like protein complex that participates in mRNA degradation. EMBO J 19: 1661–1671.

    Article  CAS  Google Scholar 

  • Draghici S, Khatri P, Bhavsar P, Shah A, Krawetz SA, Tainsky MA . (2003a). Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate. Nucleic Acids Res 31: 3775–3781.

    Article  CAS  Google Scholar 

  • Draghici S, Khatri P, Martins RP, Ostermeier GC, Krawetz SA . (2003b). Global functional profiling of gene expression. Genomics 81: 98–104.

    Article  CAS  Google Scholar 

  • Draghici S . (2003c). Data Analysis Tools for DNA Microarrays. Chapman and Hall/CRC Press: Boca Raton, FL, USA.

    Book  Google Scholar 

  • Ethier SP . (1996). Human breast cancer cell lines as models of growth regulation and disease progression. J Mammary Gland Biol Neoplasia 1: 111–121.

    Article  CAS  Google Scholar 

  • Ethier SP, Moorthy R . (1991). Multiple growth factor independence in rat mammary carcinoma cells. Breast Cancer Res Treat 18: 73–81.

    Article  CAS  Google Scholar 

  • Ethier SP, Summerfelt RM, Cundiff KC, Asch BB . (1991). The influence of growth factors on the proliferative potential of normal and primary breast cancer-derived human breast epithelial cells. Breast Cancer Res Treat 17: 221–230.

    Article  CAS  Google Scholar 

  • Forozan F, Veldman R, Ammerman CA, Parsa NZ, Kallioniemi A, Kallioniemi OP et al. (1999). Molecular cytogenetic analysis of 11 new breast cancer cell lines. Br J Cancer 81: 1328–1334.

    Article  CAS  Google Scholar 

  • Fraser MM, Watson PM, Fraig MM, Kelley JR, Nelson PS, Boylan AM et al. (2005). CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability. Cancer Res 65: 6228–6236.

    Article  CAS  Google Scholar 

  • Garcia MJ, Pole JC, Chin SF, Teschendorff A, Naderi A, Ozdag H et al. (2005). A 1 Mb minimal amplicon at 8p11–12 in breast cancer identifies new candidate oncogenes. Oncogene 24: 5235–5245.

    Article  CAS  Google Scholar 

  • Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F, Rouge C et al. (2005). Comprehensive profiling of 8p11–12 amplification in breast cancer. Mol Cancer Res 3: 655–667.

    Article  CAS  Google Scholar 

  • He W, Parker R . (2000). Functions of Lsm proteins in mRNA degradation and splicing. Curr Opin Cell Biol 12: 346–350.

    Article  CAS  Google Scholar 

  • Ingelfinger D, Arndt-Jovin DJ, Luhrmann R, Achsel T . (2002). The human LSm1-7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci. RNA 8: 1489–1501.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kelley JR, Fraser MM, Hubbard JM, Watson DK, Cole DJ . (2003). CaSm antisense gene therapy: a novel approach for the treatment of pancreatic cancer. Anticancer Res 23: 2007–2013.

    CAS  PubMed  Google Scholar 

  • Khatri P, Bhavsar P, Bawa G, Draghici S . (2004). Onto-Tools: an ensemble of web-accessible, ontology-based tools for the functional design and interpretation of high-throughput gene expression experiments. Nucleic Acids Res 32(Web Server issue): W449–W456.

    Article  CAS  Google Scholar 

  • Khatri P, Draghici S, Ostermeier GC, Krawetz SA . (2002). Profiling gene expression using onto-express. Genomics 79: 266–270.

    Article  CAS  Google Scholar 

  • Khatri P, Sellamuthu S, Malhotra P, Amin K, Done A, Draghici P . (2005). Recent additions and improvements to the Onto-Tools. Nucleic Acids Res 33(Web Server issue): W762–W765.

    Article  CAS  Google Scholar 

  • Li C, Wong WH . (2001). Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98: 31–36.

    Article  CAS  Google Scholar 

  • Livak KJ, Schmittgen TD . (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25: 402–408.

    Article  CAS  Google Scholar 

  • Paddison PJ, Caudy AA, Hannon GJ . (2002). Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci USA 99: 1443–1448.

    Article  CAS  Google Scholar 

  • Paddison PJ, Hannon GJ . (2003). siRNAs and shRNAs: skeleton keys to the human genome. Curr Opin Mol Ther 5: 217–224.

    CAS  PubMed  Google Scholar 

  • Prentice LM, Shadeo A, Lestou VS, Miller MA, deLeeuw RJ, Makretsov N et al. (2005). NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis. Oncogene 24: 7281–7289.

    Article  CAS  Google Scholar 

  • Ray ME, Yang ZQ, Albertson D, Kleer CG, Washburn JG, Macoska JA et al. (2004). Genomic and expression analysis of the 8p11–12 amplicon in human breast cancer cell lines. Cancer Res 64: 40–47.

    Article  CAS  Google Scholar 

  • Schweinfest CW, Graber MW, Chapman JM, Papas TS, Baron PL, Watson DK . (1997). CaSm: an Sm-like protein that contributes to the transformed state in cancer cells. Cancer Res 57: 2961–2965.

    CAS  PubMed  Google Scholar 

  • Sheth U, Parker R . (2003). Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 300: 805–808.

    Article  CAS  Google Scholar 

  • Surmacz E . (2000). Function of the IGF-I receptor in breast cancer. J Mammary Gland Biol Neoplasia 5: 95–105.

    Article  CAS  Google Scholar 

  • Woods Ignatoski KM, Dziubinski ML, Ammerman C, Ethier SP . (2005). Cooperative interactions of HER-2 and HPV-16 oncoproteins in the malignant transformation of human mammary epithelial cells. Neoplasia 7: 788–798.

    Article  CAS  Google Scholar 

  • Yan Y, Rubinchik S, Wood AL, Gillanders WE, Dong JY, Watson DK et al. (2006). Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer. Mol Ther 13: 357–365.

    Article  CAS  Google Scholar 

  • Yang ZQ, Albertson D, Ethier SP . (2004). Genomic organization of the 8p11–p12 amplicon in three breast cancer cell lines. Cancer Genet Cytogenet 155: 57–62.

    Article  CAS  Google Scholar 

  • Zaric B, Chami M, Remigy H, Engel A, Ballmer-Hofer K, Winkler FK et al. (2005). Reconstitution of two recombinant LSm protein complexes reveals aspects of their architecture, assembly, and function. J Biol Chem 280: 16066–16075.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from the National Cancer Institute (RO1 CA100724). Microarray experiments and analysis were performed by the Applied Genomics Technology Center at Wayne State University, which is funded by the Cancer Center Support Grant (P30 CA022453-25). Funding for Dr Sorin Draghici was provided by the following grants: NSF DBI-0234806, NIH R01 HG003491, NIH(NCRR) 1S10 RR01785701, NIH R21 CA10074001, 1R21 EB0099001 and 1R01NS04520701.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K L Streicher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Streicher, K., Yang, Z., Draghici, S. et al. Transforming function of the LSM1 oncogene in human breast cancers with the 8p11–12 amplicon. Oncogene 26, 2104–2114 (2007). https://doi.org/10.1038/sj.onc.1210002

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210002

Keywords

This article is cited by

Search

Quick links